口服依诺昔酮对严重充血性心力衰竭的不同血流动力学效应。 - Suppr | 超能文献

Differential hemodynamic effects of oral enoximone in severe congestive heart failure.

作者信息

Murali S, Uretsky B F, Betschart A R, Tokarczyk T R, Kolesar J A, Reddy P S

机构信息

Division of Cardiology, Presbyterian-University Hospital, Pittsburgh, Pennsylvania 15213.

出版信息

Am J Cardiol. 1990 Feb 15;65(7):515-9. doi: 10.1016/0002-9149(90)90822-i.

DOI:10.1016/0002-9149(90)90822-i

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Differential hemodynamic effects of oral enoximone in severe congestive heart failure.口服依诺昔酮对严重充血性心力衰竭的不同血流动力学效应。

Am J Cardiol. 1990 Feb 15;65(7):515-9. doi: 10.1016/0002-9149(90)90822-i.

2

Effects of low dose enoximone for chronic congestive heart failure.低剂量依诺昔酮对慢性充血性心力衰竭的影响。

Am J Cardiol. 1987 Aug 14;60(5):80C-84C. doi: 10.1016/0002-9149(87)90532-7.

3

A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.口服依诺昔酮对充血性心力衰竭患者局部血流动力学影响的初步报告。

Am J Cardiol. 1987 Aug 14;60(5):27C-30C. doi: 10.1016/0002-9149(87)90521-2.

4

Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.

Am J Cardiol. 1987 Aug 14;60(5):75C-79C. doi: 10.1016/0002-9149(87)90531-5.

5

Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.

Am J Cardiol. 1987 Aug 14;60(5):57C-62C. doi: 10.1016/0002-9149(87)90527-3.

6

Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.非糖苷类、非儿茶酚胺类正性肌力药物治疗充血性心力衰竭

Am J Med. 1986 Feb 28;80(2B):36-9. doi: 10.1016/0002-9343(86)90142-7.

7

A dose-response study of intravenous enoximone in congestive heart failure.充血性心力衰竭患者静脉注射依诺昔酮的剂量反应研究。

Am J Cardiol. 1987 Aug 14;60(5):31C-36C. doi: 10.1016/0002-9149(87)90522-4.

8

A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.

Am J Cardiol. 1987 Aug 14;60(5):72C-74C. doi: 10.1016/0002-9149(87)90530-3.

9

Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.

J Am Coll Cardiol. 1984 Nov;4(5):884-9. doi: 10.1016/s0735-1097(84)80047-9.

10

Electrophysiologic effects of enoximone in patients with congestive heart failure.依诺昔酮对充血性心力衰竭患者的电生理效应。

J Cardiovasc Pharmacol. 1989;14 Suppl 1:S29-32.

引用本文的文献

1

Enoximone. A review of its pharmacological properties and therapeutic potential.依诺昔酮。对其药理特性及治疗潜力的综述。

Drugs. 1991 Dec;42(6):997-1017. doi: 10.2165/00003495-199142060-00008.

2

Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.口服依诺昔酮对充血性心力衰竭患者血流动力学、运动能力、无氧阈值及心律失常的短期影响。

Klin Wochenschr. 1991 Jul 22;69(10):430-5. doi: 10.1007/BF01666828.